CD8A and neoplasm: Rios-Doria et al. characterized several xenograft models using humanized mice and revealed that the antitumor response of the models to immunotherapy was positively associated with the induced levels of CD4 and CD8 tumor-infiltrating lymphocytes (Rios-Doria et al., 2020).